Clinical Trial Update: EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 trial results for EPO906 in combination with radiation therapy in cancer patients, including central nervous system neoplasms and head and neck neoplasm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Neoplasms
• Head and Neck Neoplasms

Drugs mentioned

• EPO906

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Central Nervous System Neoplasms, Head and Neck Neoplasms | Phase 1 | Status: COMPLETED